Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Document › Details

Reuters. (6/23/17). "News: BRIEF – Gensight Biologics Raises 22.5 Million Euros".

Organisations Organisation GenSight Biologics S.A. (Euronext: SIGHT)
  Organisation 2 INSTITUTIONAL INVESTOR/S
  Group OTHER
Products Product lenadogene nolparvovec (GS010)
  Product 2 investment banking
Index term Index term GenSight Biologics–SEVERAL: investment, 201706 capital increase €22.5m €6/share with Europ + US institutional investors
     


   
Record changed: 2023-06-05

Advertisement

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for GenSight Biologics S.A. (Euronext: SIGHT)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Top News Bayer Aignostics Collaboration 650x300px




» top